Clinical Trials Browser

Phase 3 × Burkitt Lymphoma × hydrocortisone hemisuccinate × Clear all

NCT02883049 2026-06-02

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations

Phase 3 Completed

5,949 enrolled 28 charts

Burkitt Lymphoma